07 February 2017

Sphere Medical Holding plc: Notice of Preliminary Results


Notice of Preliminary Results

Sphere Medical Holding plc (AIM: SPHR.L), an innovative point-of-care monitoring and diagnostic devices company,will announce its preliminary results for the year ended 31 December 2016 on Tuesday 28 February 2017.

For further information, please contact:

Sphere Medical Holding plc
Dr Wolfgang Rencken, Chief Executive Officer
Richard Wright, Chief Financial Officer
Tel: +44 (0)1223 875 222

Panmure Gordon
Freddy Crossley (Corporate Finance)
Duncan Monteith (Corporate Finance)
Tom Salvesen (Corporate Broking)
Tel: +44 (0) 20 7886 2500

Consilium Strategic Communications
Mary-Jane Elliott
Ivar Milligan
Hendrik Thys
Tel: +44 (0) 20 3709 5700
spheremedical@consilium-comms.com

Notes for editors
About Sphere Medical (AIM: SPHR.L)

Sphere Medical is an innovative point-of-care medical device company. Its Proxima platform measures blood gases, electrolytes and metabolites at the patient’s bedside and aims to improve patient care and reduce health system costs. The device is sold directly to the critical care market via Sphere Medical’s sales force in the UK, Germany, The Netherlands and Belgium and via distributors in Italy and Spain. For further information, please visit www.spheremedical.com.


Back to previous page